What is the ticker symbol for 10x Genomics, Inc.?

The ticker symbol for 10x Genomics, Inc. is NASDAQ:TXG

Does 10x Genomics, Inc. pay dividends?

No, 10x Genomics, Inc. does not pay dividends

What sector is 10x Genomics, Inc. in?

10x Genomics, Inc. is in the Healthcare sector

What industry is 10x Genomics, Inc. in?

10x Genomics, Inc. is in the Medical Devices industry

What country is 10x Genomics, Inc. based in?

10x Genomics, Inc. is headquartered in United States

When did 10x Genomics, Inc. go public?

10x Genomics, Inc. initial public offering (IPO) was on September 12, 2019

Is 10x Genomics, Inc. in the S&P 500?

No, 10x Genomics, Inc. is not included in the S&P 500 index

Is 10x Genomics, Inc. in the NASDAQ 100?

No, 10x Genomics, Inc. is not included in the NASDAQ 100 index

Is 10x Genomics, Inc. in the Dow Jones?

No, 10x Genomics, Inc. is not included in the Dow Jones index

When was 10x Genomics, Inc. last earnings report?

10x Genomics, Inc.'s most recent earnings report was on August 6, 2026

When does 10x Genomics, Inc. report earnings?

The next expected earnings date for 10x Genomics, Inc. is November 5, 2026

TXG Stock Financials, Chart, Sentiment & Profile

Summary

Current Price: As of today, TXG price is $73.64, up +2.92% in the most recent trading session on October 26, 2026
Current Price All-Time High: TXG price is currently -64.76% below its historical high of $208.99 set on June 29, 2021
Market Cap: TXG current market cap is $10B, up +450.64% over the past 365 days
Revenue: TXG current annual revenue is $642.82M, up +5.25% year-over-year
Next Earnings: The next earnings release for TXG is on November 5, 2026

Profile

Company profile for 10x Genomics, Inc. (TXG)
Metric	Value
Full Name	10x Genomics, Inc.
Ticker	NASDAQ: TXG
Exchange	NASDAQ
Sector	Healthcare
Industry	Medical Devices
Country	United States
IPO	Sep 12, 2019
Indexes	Not included
Website	10xgenomics.com
Employees	1,306

Key Metrics

10x Genomics, Inc. Key Details
Metric	Value	Date
Price	$73.64	Oct 26, 26
Price, 1D Change	+2.92%	Oct 26, 26
Market Cap	$10B	Oct 26, 26
	-	Oct 26, 26
PE Ratio	-	Oct 26, 26
Beta	2.23	Oct 23, 26
Revenue	$642.82M	Dec 31, 25
Revenue, 1Y Change	+5.25%	Dec 31, 25
EPS	-$0.35	Dec 31, 25
EPS, 1Y Change	+76.98%	Dec 31, 25

Events

10x Genomics, Inc. Events
Metric	Value	Date
Next Earnings		Nov 5, 26
Last Qtr. Earnings		Aug 6, 26
Last Ann. Earnings		Feb 12, 26
Last Ex-Dividend	N/A	N/A
Next Ex-Dividend	N/A	N/A
Last Split	1:2	Jul 17, 06
Next Split	N/A	N/A
Last Ticker Change	N/A	N/A
Next Ticker Change	N/A	N/A

🔒 Log In To Unlock Full Data

Estimates

TXG Estimates
Metric	Value	Date
EPS	-$0.35	Dec 31, 25
EPS Estimate	$0.04	N/A
EPS Est. Change	+110.51%	N/A
Revenue	$642.82M	Dec 31, 25
Revenue Estimate	$620.66M	N/A
Revenue Est. Change	-3.45%	N/A
Current Price	$73.64	Oct 26, 26
Price Target	$70.00	-
Price Tgt. Change	-4.94%	-

🔒 Log In To Unlock Full Data

EPS

TXG EPS reported versus estimate values
Year	Estimate	Reported	Surprise / Exp.
2024	-$0.61	-$1.52	-147.22%
2025	-$0.03	-$0.35	-1,207.49%
2026	$0.04	N/A	+110.51%
2027	$0.08	N/A	+121.97%

Revenue

TXG revenue reported versus estimate values chart
Year	Estimate	Reported	Surprise / Exp.
2024	$610.74M	$610.79M	+0.01%
2025	$640.23M	$642.82M	+0.41%
2026	$620.66M	N/A	-3.45%
2027	$683.56M	N/A	+6.34%

🔒 Log In To Unlock Full Data

Performance

TXG Performance
Metric	Value	Date
Price, 1Y	+434.79%	Oct 26, 26
Price, 3Y	+97.48%	Oct 26, 26
Market Cap, 1Y	+450.64%	Oct 26, 26
Market Cap, 3Y	+117.68%	Oct 26, 26
Revenue, 1Y	+5.25%	Dec 31, 25
Revenue, 3Y	+24.48%	Dec 31, 25
EPS, 1Y	+76.98%	Dec 31, 25
EPS, 3Y	+76.06%	Dec 31, 25

🔒 Log In To Unlock Full Data

Technicals

TXG Technical Indicators
Metric	Value	Date
Current Price	$73.64	Oct 26, 26
SMA 200	$39.15	Oct 23, 26
SMA 50	$72.36	Oct 23, 26
EMA 200	$45.99	Oct 23, 26
EMA 50	$70.54	Oct 23, 26
MACD	-$1.02	Oct 23, 26
Beta	2.23	Oct 23, 26
ATR	$6.41	Oct 23, 26
14-Day RSI	45.95	Oct 23, 26
10-Day Volatility	70.09%	Oct 23, 26

Dividends

TXG Dividends
Metric	Value	Date
	-	N/A
Upcoming	N/A	N/A
	-	Oct 26, 26
	-	Dec 31, 25
	$0.00	Dec 31, 25
	0.00%	Dec 31, 25

🔒 Log In To Unlock Full Data

Income & Profitability

TXG Income & Profitability
Metric	Value	Date
Revenue	$642.82M	Dec 31, 25
EPS	-$0.35	Dec 31, 25
Gross Profit	$443.88M	Dec 31, 25
Gross Margin	69.05%	Dec 31, 25
Operating Income	-$110.89M	Dec 31, 25
Operating Margin	-17.25%	Dec 31, 25
Net Income	-$43.54M	Dec 31, 25
Net Margin	-6.77%	Dec 31, 25
EBITDA	-$56.38M	Dec 31, 25

🔒 Log In To Unlock Full Data

Financial Health

TXG Financial Health
Metric	Value	Date
Debt To Equity	0.11	Dec 31, 25
	4.46	Dec 31, 25
	4.09	Dec 31, 25
	-	Dec 31, 25
	4	Jun 30, 26
	22.34	Oct 26, 26

Valuations

TXG Valuations
Metric	Value	Date
PE Ratio	-	Oct 26, 26
	15.55	Oct 26, 26
	11.62	Oct 26, 26
	-211.42	Oct 26, 26
	-	N/A

Balance Sheet

TXG Balance Sheet
Metric	Value	Date
Book Value	$796.33M	Dec 31, 25
	$523.41M	Dec 31, 25
	$1.04B	Dec 31, 25
	$684.45M	Dec 31, 25
	$245.04M	Dec 31, 25
	$153.45M	Dec 31, 25
Total Debt	$84.36M	Dec 31, 25
	$10.99M	Dec 31, 25
	$12.73M	Dec 31, 25

Expenses

TXG Expenses
Metric	Value	Date
	$686.37M	Dec 31, 25
	$554.77M	Dec 31, 25
	$198.94M	Dec 31, 25
	$0.00	Dec 31, 25
	$43.82M	Dec 31, 25
	$0.00	Dec 31, 25
	$3.64M	Dec 31, 25

Cash Flow

TXG Cash Flow
Metric	Value	Date
	$136.05M	Dec 31, 25
	-$13.44M	Dec 31, 25
	$6.80M	Dec 31, 25
Capex	$5.94M	Dec 31, 25
	$130.12M	Dec 31, 25

Recent analyst updates

TXG Recent analyst updates
Metric	Value	Date
TD Cowen	→	Oct 13, 26
Morgan Stanley	→	Oct 13, 26
Canaccord Genuity	→	Oct 12, 26
Barclays	→	Oct 7, 26
Leerink Partners	→	Sep 29, 26
Piper Sandler	→	Sep 28, 26
Argus Research		Sep 28, 26
UBS	→	Sep 9, 26
RBC Capital		Sep 1, 26
Stephens & Co.	→	Aug 12, 26

Analyst sentiment

Institutional ownership

No data

Screeners with TXG

FAQ

What is the ticker symbol for 10x Genomics, Inc.?: The ticker symbol for 10x Genomics, Inc. is NASDAQ:TXG
Does 10x Genomics, Inc. pay dividends?: No, 10x Genomics, Inc. does not pay dividends
What sector is 10x Genomics, Inc. in?: 10x Genomics, Inc. is in the Healthcare sector
What industry is 10x Genomics, Inc. in?: 10x Genomics, Inc. is in the Medical Devices industry
What country is 10x Genomics, Inc. based in?: 10x Genomics, Inc. is headquartered in United States
When did 10x Genomics, Inc. go public?: 10x Genomics, Inc. initial public offering (IPO) was on September 12, 2019
Is 10x Genomics, Inc. in the S&P 500?: No, 10x Genomics, Inc. is not included in the S&P 500 index
Is 10x Genomics, Inc. in the NASDAQ 100?: No, 10x Genomics, Inc. is not included in the NASDAQ 100 index
Is 10x Genomics, Inc. in the Dow Jones?: No, 10x Genomics, Inc. is not included in the Dow Jones index
When was 10x Genomics, Inc. last earnings report?: 10x Genomics, Inc.'s most recent earnings report was on August 6, 2026
When does 10x Genomics, Inc. report earnings?: The next expected earnings date for 10x Genomics, Inc. is November 5, 2026

Data Sources & References

TXG Official Website www.10xgenomics.com
Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1770787/000162828026007822/0001628280-26-007822-index.htm
TXG Profile on Yahoo Finance finance.yahoo.com/quote/TXG
TXG Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/txg